Abstract
India has a high prevalence of tuberculosis as well as diabetes mellitus, and both contribute to a major disease burden. Diabetes mellitus increases the risk of tuberculosis. Patients with diabetes are more prone to develop cavitary lesions than non-diabetics. Tuberculosis can worsen the glycemic status of an individual and anti-tuberculous drugs like Rifampicin can interact with oral anti-diabetic drugs, further worsening the glycemic control. This can result in complications related to diabetes, like diabetic amyotrophy. We hereby report the case of a 69-year-old gentleman with diabetes mellitus, who developed uncontrolled blood sugars, leading to Bruns Garland syndrome or diabetic amyotrophy on starting anti-tuberculous therapy for sputum positive pulmonary tuberculosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
